Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

bio Genous

bio Genous provides biomedical scientific research and drug development services.
2022
51-100
51-100
Hangzhou, Zhejiang, China
  • Bioanalytical Devices
  • Bioreactors
  • Drug Discovery and Development
  • Personalized Medicine Technologies
  • Services (Patient care)

Innovation

R&D Focus

Patient-derived 3D disease models for therapy selection

Innovative Solution

bio Genous provides biomedical scientific research, drug development, and clinical precision medicine services. They offer services that include organoid automation equipment, multi-tissue full-process kits, organoid culture and sample library construction technical solutions, organoid drug development, and precision medical subsystems.

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

13.08M

Last Funding Date

31-12-2024

Startup Stage

Early Stage

Lead Investors

Marathon Venture Partners, CMG-SDIC Capital Management, AstraZeneca CICC Medical Industry Fund

About

bio Genous provides biomedical scientific research, drug development, and clinical precision medicine services. They offer services that include organoid automation equipment, multi-tissue full-process kits, organoid culture and sample library construction technical solutions, organoid drug development, and precision medical subsystems.

Products

Demo Product or Complete Product?

Complete product / commercially available

Something missing or incorrect on this page? Help us enrich this information